Molecular mechanism
PACAP and VIP receptors
Receptor relationships involving PAC1, VPAC1 and VPAC2, with each ligand’s tested receptor subtype identified separately.
See this target on the receptor map
01
Neutral molecular overview
Receptor relationships involving PAC1, VPAC1 and VPAC2, with each ligand’s tested receptor subtype identified separately.
02
Target identifiers
No target identifier beyond the verified name and aliases is listed for this mechanism.
03
Related compounds
04
Related mechanisms
No related mechanism is declared in this seed record.
05
Verified bibliography
Reference 1
A structure-function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists.Ramos-Álvarez I, Mantey SA, Nakamura T, Nuche-Berenguer B, Moreno P, Moody TW, Maderdrut JL, Coy DH, Jensen RT
Peptides · 2015-02-16 · Journal Article
currentReference 2
Antibacterial properties of the pituitary adenylate cyclase-activating polypeptide: A new human antimicrobial peptide.Debbabi S, Groleau MC, Létourneau M, Narayanan C, Gosselin LL, Iddir M, Gagnon J, Doucet N, Déziel E, Chatenet D
PloS one · 2018-11-21 · Journal Article
current
Study models of these references
What kind of experiment each cited paper reports, taken from its abstract unless marked. Not a summary of results.
| Reference | Study models |
|---|---|
| Ramos-Álvarez I et al. 2015 | Study models reported: in vitro · from the abstract |
| Debbabi S et al. 2018 | Study models reported: in vitro · from the abstract |
06
Related glossary terms
07
Related Purely Peptides research articles
No existing Research Article is mapped to this mechanism seed record.